Found: 132
Select item for more details and to access through your institution.
Amalgam of ternary solid dispersion and P-gp efflux inhibition in development of colon-targeted tablets of rifaximin.
- Published in:
- Journal of Reports in Pharmaceutical Sciences, 2022, v. 11, n. 2, p. 222, doi. 10.4103/jrptps.JRPTPS_21_22
- By:
- Publication type:
- Article
An Effectiveness of Ayurveda Management in Crohn's Disease.
- Published in:
- Journal of Integrated Health Sciences, 2024, v. 12, n. 1, p. 80, doi. 10.4103/jihs.jihs_13_24
- By:
- Publication type:
- Article
On the Analytic Characteristics of Commercial Acetaminophen Assays in the United States<sup> </sup>.
- Published in:
- Journal of Applied Laboratory Medicine, 2022, v. 7, n. 6, p. 1311, doi. 10.1093/jalm/jfac059
- By:
- Publication type:
- Article
Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3468, doi. 10.3390/cells11213468
- By:
- Publication type:
- Article
Preparation of S-Scheme g-C 3 N 4 /ZnO Heterojunction Composite for Highly Efficient Photocatalytic Destruction of Refractory Organic Pollutant.
- Published in:
- Catalysts (2073-4344), 2023, v. 13, n. 3, p. 485, doi. 10.3390/catal13030485
- By:
- Publication type:
- Article
Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1361501
- By:
- Publication type:
- Article
Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1029, doi. 10.1111/apt.14361
- By:
- Publication type:
- Article
Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4502, doi. 10.3390/nu15214502
- By:
- Publication type:
- Article
Efficacy of a 1 day Rifaximin and Metronidazole Regimen and Mechanical Bowel Preparation for Preventing Surgical Site Infection in Minimally Invasive Colorectal Cancer Surgery: A Prospective Observational Study.
- Published in:
- American Surgeon, 2024, v. 90, n. 4, p. 550, doi. 10.1177/00031348231200667
- By:
- Publication type:
- Article
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203200
- By:
- Publication type:
- Article
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 12, p. 2090, doi. 10.1093/cid/ciad083
- By:
- Publication type:
- Article
Inappropriateness of Using Rifampicin E-Test to Predict Rifabutin Resistance in Helicobacter pylori.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, p. S479, doi. 10.1093/infdis/jiac417
- By:
- Publication type:
- Article
Rifaximin Protects against Malathion-Induced Rat Testicular Toxicity: A Possible Clue on Modulating Gut Microbiome and Inhibition of Oxidative Stress by Mitophagy.
- Published in:
- Molecules, 2022, v. 27, n. 13, p. 4069, doi. 10.3390/molecules27134069
- By:
- Publication type:
- Article
利福昔明联合枯草杆菌二联活菌治疗 小肠细菌过度生长的研究.
- Published in:
- Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 14, p. 1815, doi. 10.3969/j.issn.1006-5725.2023.14.015
- By:
- Publication type:
- Article
Diverticular Disease and Rifaximin: An Evidence-Based Review.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 443, doi. 10.3390/antibiotics12030443
- By:
- Publication type:
- Article
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 12, p. 1680, doi. 10.3390/antibiotics11121680
- By:
- Publication type:
- Article
Post Marketing Observational Study of Fixed Dose Combination of Rifaximin and Metronidazole in The Management of Acute Diarrhea.
- Published in:
- Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2023, v. 24, n. 2, p. 122, doi. 10.24871/2422023122-126
- By:
- Publication type:
- Article
Norfloxacin versus rifaximin for spontaneous bacterial peritonitis prophylaxis: A randomized controlled trial.
- Published in:
- Journal of Krishna Institute of Medical Sciences (JKIMSU), 2024, v. 13, n. 1, p. 112
- By:
- Publication type:
- Article
Antibiotics and Probiotics for Irritable Bowel Syndrome.
- Published in:
- Drugs, 2023, v. 83, n. 8, p. 687, doi. 10.1007/s40265-023-01871-y
- By:
- Publication type:
- Article
Modeling and Optimization of Hybrid Fenton and Ultrasound Process for Crystal Violet Degradation Using AI Techniques.
- Published in:
- Water (20734441), 2023, v. 15, n. 24, p. 4274, doi. 10.3390/w15244274
- By:
- Publication type:
- Article
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0270786
- By:
- Publication type:
- Article
Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267647
- By:
- Publication type:
- Article
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264278
- By:
- Publication type:
- Article
Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function.
- Published in:
- PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0264459
- By:
- Publication type:
- Article
Effect of subinhibitory doses of rifaximin on in vitro Pseudomonas aeruginosa adherence and biofilm formation to biotic and abiotic surface models.
- Published in:
- Polimery w Medycynie, 2023, v. 53, n. 2, p. 97, doi. 10.17219/pim/166584
- By:
- Publication type:
- Article
Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat.
- Published in:
- Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/4078681
- By:
- Publication type:
- Article
Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14727, doi. 10.3390/ijms241914727
- By:
- Publication type:
- Article
The Link between Gut Microbiota and Hepatic Encephalopathy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 8999, doi. 10.3390/ijms23168999
- By:
- Publication type:
- Article
Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7383, doi. 10.3390/ijms23137383
- By:
- Publication type:
- Article
Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 5064, doi. 10.3390/ijms23095064
- By:
- Publication type:
- Article
Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci.
- Published in:
- Liver International, 2023, v. 43, n. 9, p. 2039, doi. 10.1111/liv.15667
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. i, doi. 10.1111/liv.15543
- By:
- Publication type:
- Article
Rifaximin stimulates nitrogen detoxification by PXR‐independent mechanisms in human small intestinal organoids.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 649, doi. 10.1111/liv.15491
- By:
- Publication type:
- Article
Rifaximin for severe alcoholic hepatitis—Attractive but unfructuous.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1698, doi. 10.1111/liv.15294
- By:
- Publication type:
- Article
Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH).
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1109, doi. 10.1111/liv.15207
- By:
- Publication type:
- Article
Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 2, p. 295, doi. 10.1111/liv.13551
- By:
- Publication type:
- Article
Evaluation of Combining Ability and Heterosis for Earliness and Growth Traits of some Sunflower Genotypes under Water Stress Conditions.
- Published in:
- Journal of Plant Production, 2022, v. 13, n. 8, p. 565, doi. 10.21608/jpp.2022.151438.1145
- By:
- Publication type:
- Article
利福昔明在肝硬化相关并发症中的应用.
- Published in:
- Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2018, v. 34, n. 7, p. 1551, doi. 10.3969/j.issn.1001-5256.2018.07.040
- By:
- Publication type:
- Article
Mean Blood Ammonia Level After Treatment With Rifaximin Versus Neomycin In Chronic Liver Disease Patients Presenting With Hepatic Encephalopathy.
- Published in:
- Annals of King Edward Medical University, 2019, v. 25, n. 1, p. 1
- By:
- Publication type:
- Article
Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69162-4
- By:
- Publication type:
- Article
Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69162-4
- By:
- Publication type:
- Article
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1121435
- By:
- Publication type:
- Article
Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
- Published in:
- Frontiers in Microbiology, 2023, v. 14, p. 1, doi. 10.3389/fmicb.2023.1091167
- By:
- Publication type:
- Article
Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 3733, doi. 10.2147/IDR.S371131
- By:
- Publication type:
- Article
Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-023-04844-7
- By:
- Publication type:
- Article
The Comparison of Two Different Intrauterine Treatment Efficiency in Repeat Breeder Cows.
- Published in:
- Kocatepe Veterinary Journal / Kocatepe Veteriner Dergisi, 2022, v. 15, n. 4, p. 476, doi. 10.30607/kvj.1166315
- By:
- Publication type:
- Article
Cefacetrile and Rifaximin association might improve first service conception rate and reduce the number of services per conception in cows with clinical endometritis.
- Published in:
- Veterinarska Stanica, 2022, v. 53, n. 3, p. 273, doi. 10.46419/vs.53.3.1
- By:
- Publication type:
- Article
Probing gut-brain links in Alzheimer's disease with rifaximin.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12225
- By:
- Publication type:
- Article
Rifaximin protects SH‐SY5Y neuronal cells from iron overload‐induced cytotoxicity via inhibiting STAT3/NF‐κB signaling.
- Published in:
- Cell Biology International, 2022, v. 46, n. 7, p. 1062, doi. 10.1002/cbin.11776
- By:
- Publication type:
- Article
Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Inflammatory Intestinal Diseases, 2024, v. 9, n. 1, p. 22, doi. 10.1159/000536124
- By:
- Publication type:
- Article